Highbridge Capital Management LLC reduced its position in shares of Danaher Corporation (NYSE:DHR) by 21.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 4,477 shares of the conglomerate’s stock after selling 1,200 shares during the period. Highbridge Capital Management LLC’s holdings in Danaher Corporation were worth $383,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Peddock Capital Advisors LLC boosted its position in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares during the last quarter. ClariVest Asset Management LLC bought a new position in Danaher Corporation during the first quarter worth $157,000. Motco boosted its position in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares during the last quarter. Baystate Wealth Management LLC boosted its position in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares during the last quarter. Finally, Cedar Wealth Management LLC boosted its position in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock worth $196,000 after buying an additional 115 shares during the last quarter. Hedge funds and other institutional investors own 76.56% of the company’s stock.

Danaher Corporation (NYSE DHR) traded up 0.67% during mid-day trading on Friday, reaching $79.82. 2,433,944 shares of the company’s stock traded hands. The company has a market cap of $55.45 billion, a P/E ratio of 25.48 and a beta of 1.03. The stock has a 50 day moving average of $82.89 and a 200 day moving average of $84.21. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter in the previous year, the firm earned $0.90 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities research analysts predict that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Danaher Corporation (NYSE:DHR) Shares Sold by Highbridge Capital Management LLC” was posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/12/danaher-corporation-nysedhr-shares-sold-by-highbridge-capital-management-llc.html.

A number of research firms have weighed in on DHR. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub cut shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. Wells Fargo & Company began coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a “market perform” rating and a $90.00 target price on the stock. Zacks Investment Research cut shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Finally, BTIG Research reiterated a “buy” rating and issued a $92.00 target price on shares of Danaher Corporation in a research note on Sunday, April 23rd. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $91.76.

In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of Danaher Corporation stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the transaction, the director now owns 42,151 shares of the company’s stock, valued at $3,499,797.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now directly owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold 38,623 shares of company stock worth $3,206,426 in the last ninety days. Insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.